The Pennine Acute Hospitals
NHS Trust Formulary
 
back
8 Malignant disease and immunosuppression
08-02-04 Lenalidomide, pomalidomide, and thalidomide

Thalidomide Thalidomide Celgene®
Formulary
Capsules
Link  THALIDOMIDE CELGENE™ (thalidomide) Healthcare Professional’s Information Pack (HCPIP)
Link  Male treatment initiation form
Link  Prescription authorisation form
Link  Women of childbearing potential initiation form
Link  Women of non-childbearing potential initiation form
Link  NICE TA228: bortezomib and thalidomide for the first-line treatment of multiple myeloma.
 

Red View adult BNF  View SPC online  View childrens BNF
Lenalidomide Revlimid®
Formulary
Capsules
Link  REVLIMID® (lenalidomide) Healthcare Professional’s Information Pack (HCPIP)
Link  Revlimid® Prescription Authorisation Form
Link  NICE TA171: Lenalidomide for the treatment of multiple myeloma
Link  NICE TA322: Lenalidomide for treating myelodysplastic syndromes associated with an isolated deletion 5q cytogenetic abnormality
 

Red View adult BNF  View SPC online  View childrens BNF  CDF
Pomalidomide
Formulary
Capsules

View adult BNF  View SPC online  View childrens BNF  CDF